RBF Capital’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$46.4K Hold
17,391
﹤0.01% 584
2025
Q1
$140K Hold
17,391
0.01% 518
2024
Q4
$168K Sell
17,391
-2,131
-11% -$20.6K 0.01% 507
2024
Q3
$363K Hold
19,522
0.02% 468
2024
Q2
$325K Buy
+19,522
New +$325K 0.02% 467